CC BY-NC-ND 4.0 · Indian J Cardiovasc Dis Women WINCARS 2021; 06(04): 256-260
DOI: 10.1055/s-0041-1742212

1   ASRAM Medical College, Department of Cardiology, ASRAMS, Eluru, Andhra Pradesh, India

› Author Affiliations Funding No sources of research supporter funding, equipment, and drugs.
This manuscript highlights the importance of zoonotic diseases and the need of high index of suspicion for the diagnosis of this latent infection.
   Permissions and Reprints Abstract

Brucella endocarditis is one of the rare, life-threatening complications of a multisystemic zoonotic disease, brucellosis. Careful history taking, clinical examinations, and detailed laboratory tests with special culture media in endemic zones help in diagnosis of this latent disease. No consensus on the exact management of this disease has reached till now. Hence, both medical management and surgical interventions in selective cases were the treatment of choice. This article provides a review of the earlier literature on Brucella endocarditis.

Keywords Brucellosis - endocarditis - multimodality approach - combined management Publication History

Publication Date:
15 February 2022 (online)

© 2022. Women in Cardiology and Related Sciences. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  References 1 Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006; 6 (02) 91-99 2 Zheng R, Xie S, Lu X. et al. A systematic review and meta-analysis of epidemiology and clinical manifestations of human brucellosis in China. BioMed Res Int 2018; 2018: 5712920 3 Bukhari EE. Pediatric brucellosis. An update review for the new millennium. Saudi Med J 2018; 39 (04) 336-341 DOI: 10.15537/smj.2018.4.21896. 4 Mirnejad R, Jazi FM, Mostafaei S, Sedighi M. Molecular investigation of virulence factors of Brucella melitensis and Brucella abortus strains isolated from clinical and non-clinical samples. Microb Pathog 2017; 109: 8-14 5 Greenfield RA, Drevets DA, Machado LJ, Voskuhl GW, Cornea P, Bronze MS. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci 2002; 323 (06) 299-315 6 Peery TM, Belter LF. Brucellosis and heart disease. II. Fatal brucellosis: a review of the literature and report of new cases. Am J Pathol 1960; 36: 673-697 7 Halim M, Jeroudi M, Mercer E. et al. Infective endocarditis in King Faisal Specialist Hospital, review of 35 consecutive adult patients. Ann Saudi Med 1986; 6: 179-183 8 Dalrymple-Champneys W. Brucella Infection and Undulent Fever in Man. London: Oxford University Press; 1960: 1 9 Aygen B, Doğanay M, Sümerkan B, Yıldız O, Kayabaş Ü. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Mal Infect 2002; 32: 485-493 10 Spink WW. The n Nature of Brucellosis. Minneapolis: University of Minnesota Press; 1956: 145-190 11 Reguera JM, Alarcón A, Miralles F, Pachón J, Juárez C, Colmenero JD. Brucella endocarditis: clinical, diagnostic, and therapeutic approach. Eur J Clin Microbiol Infect Dis 2003; 22 (11) 647-650 12 Calik S, Gokengin D. Human brucellosis in Turkey: a review of the literature between 1990 and 2009. Turk J Med Sci 2011; 41: 549-555 13 Ulu-Kilic A, Metan G, Alp E. Clinical presentations and diagnosis of brucellosis. Recent Pat Antiinfect Drug Discov 2013; 8 (01) 34-41 14 Cay S, Cagirci G, Maden O, Balbay Y, Aydogdu S. Brucella endocarditis - a registry study. Kardiol Pol 2009; 67 (03) 274-280 15 Jeroudi MO, Halim MA, Harder EJ, Al-Siba'i MB, Ziady G, Mercer EN. Brucella endocarditis. Br Heart J 1987; 58 (03) 279-283 16 E. Williams, Brucellosis, practitioner 226(1982):1507 17 Anderson DJ, Goldstein LB, Wilkinson WE. et al. Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology 2003; 61 (10) 1341-1346 18 Cabell CH, Pond KK, Peterson GE. et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001; 142 (01) 75-80 19 Mert A, Kocak F, Ozaras R. et al. The role of antibiotic treatment alone for the management of Brucella endocarditis in adults: a case report and literature review. Ann Thorac Cardiovasc Surg 2002; 8 (06) 381-385 20 Fernández-Guerrero ML. Zoonotic endocarditis. Infect Dis Clin North Am 1993; 7 (01) 135-152 21 Gunes Y, Tuncer M, Guntekin U. et al. Clinical characteristics and outcome of Brucella endocarditis. Trop Doct 2009; 39 (02) 85-88 22 Esmailpour N, Borna S, Nejad MR, Badie SM, Badie BM, Hadadi A. Brucella endocarditis: a report from Iran. Trop Doct 2010; 40 (01) 47-49 23 Baysallar M, Aydogan H, Kilic A, Kucukkaraaslan A, Senses Z, Doganci L. Evaluation of the BacT/ALERT and BACTEC 9240 automated blood culture systems for growth time of Brucella species in a Turkish tertiary hospital. Med Sci Monit 2006; 12 (07) BR235-BR238 24 Fonseca JP, Pereiro T, Dos Santos DP, Correia JM, Capelo J, Carragoso A. A. Successful management of prosthetic valve Brucella endocarditis with antibiotherapy alone. Eur J Case Rep Intern Med 2018; 5 (04) 000808 25 Christopher S, Umapathy BL, Ravikumar KL. Brucellosis: review on the recent trends in pathogenicity and laboratory diagnosis. J Lab Physicians 2010; 2 (02) 55-60 26 Al Dahouk S, Tomaso H, Nockler K, Neubauer H, Frangoulidis D. Laboratory-based diagnosis of brucellosis—a review of the literature. Part I: Techniques for direct detection and identification of Brucella spp. Clin Lab (Zaragoza) •••; 49: 487-505 27 Cutler SJ, Whatmore AM, Commander NJ. Brucellosis–new aspects of an old disease. J Appl Microbiol 2005; 98 (06) 1270-1281 28 Shapira N, Merin O, Rosenmann E. et al. Latent infective endocarditis: epidemiology and clinical characteristics of patients with unsuspected endocarditis detected after elective valve replacement. Ann Thorac Surg 2004; 78 (05) 1623-1629 29 Keleş C, Bozbuğa N, Sişmanoğlu M. et al. Surgical treatment of Brucella endocarditis. Ann Thorac Surg 2001; 71 (04) 1160-1163 30 Keshtkar-Jahromi M, Boroumand M, Razavi SM. et al. Brucella endocarditis, a report of 14 cases (1991-2009). J Infect 2010; 61 (01) 89-92 31 Hamieh A, Hamieh M. Brucella prosthetic valve endocarditis with septic and cardiogenic shock. IDCases 2020; 21: e00881 32 Raju IT, Solanki R, Patnaik AN, Barik RC, Kumari NR, Gulati AS. Brucella endocarditis - a series of five case reports. Indian Heart J 2013; 65 (01) 72-77 33 Mohandas N, Balasubramanian R, Prasad SB. Can brucella endocarditis be treated successfully with medical therapy alone?. Trop Doct 2009; 39 (02) 123-124 34 Koruk ST, Erdem H, Koruk I. et al. Management of Brucella endocarditis: results of the Gulhane study. Int J Antimicrob Agents 2012; 40 (02) 145-150 35 Solera J, Martínez-Alfaro E, Sáez L. [Meta-analysis of the efficacy of the combination of +rifampicin and doxycycline in the treatment of human brucellosis]. Med Clin (Barc) 1994; 102 (19) 731-738 36 Habib G, Hoen B, Tornos P. et al; ESC Committee for Practice Guidelines, Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009; 30 (19) 2369-2413 37 Joint FAO/WHO Expert Committee on Brucellosis. Sixth Report. World Health Organ Tech Rep Ser No.740. Geneva: World Health Organisation; 1986 38 Colmenero Castillo JD, Hernandez Marquez S, Reguera Iglesias JM, Cabrera Franquelo F, Rius Diaz F, Alonso A. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis. Chemotherapy 1989; 35 (02) 146-152 39 Zisis C, Argyariou M, Kokotsakis I. et al. Brucella endocarditis: presentation of two cases and literature review. Hellenic J Cardiol 2002; 43: 174-177 40 Wolf LM, Hazan E, Letac B, Courtois H, Schrub JC. Endocardite brucellienne. Guérison par remplacement valvulaire en période évolutive. Nouv Presse Med 1973; 2 (08) 493-495 41 Cohen N, Golik A, Alon I. et al. Conservative treatment for Brucella endocarditis. Clin Cardiol 1997; 20 (03) 291-294 42 Duran E, Sunar H, Ege T, Canbaz S. Excision of aortic vegetation in Brucella endocarditis. Asian Cardiovasc Thorac Ann 2001; 9: 59-61 43 Taamallah K, Hammami F, Gharsallah H, Koubaa M, Ben Jemaa M, Fehri W. Brucella prosthetic valve endocarditis: a systematic review. J Saudi Heart Assoc 2021; 33 (03) 198-212 44 Ozsöyler I, Yilik L, Bozok S. et al. Brucella endocarditis: the importance of surgical timing after medical treatment (five cases). Prog Cardiovasc Dis 2005; 47 (04) 226-229 45 Ozkokeli M, Sensoz Y, Kayacioglu I. et al. Treatment of Brucella endocarditis: our surgical experience with 6 patients. Heart Surg Forum 2005; 8 (04) E262-E265 46 Sasmazel A, Baysal A, Fedakar A. et al. Treatment of Brucella endocarditis: 15 years of clinical and surgical experience. Ann Thorac Surg 2010; 89 (05) 1432-1436 47 Heibig J, Beall Jr AC, Myers R, Harder E, Feteih N. Brucella aortic endocarditis corrected by prosthetic valve replacement. Am Heart J 1983; 106 (03) 594-596 48 Jacobs F, Abramowicz D, Vereerstraeten P, Le Clerc JL, Zech F, Thys JP. Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis 1990; 12 (05) 740-744 49 Du N, Wang F. Clinical characteristics and outcome of Brucella endocarditis. Turk J Med Sci 2016; 46 (06) 1729-1733